This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human AFP. Tacatuzumab is a humanized monoclonal antibody intended for the treatment of cancer. https://www.creativebiolabs.net/anti-afp-adcc-enhanced-antibody-tacatuzumab-105879.htm